Clinical trial
Assessing Phenytoin and Levetiracetam Efficacy, Cost-Effectiveness, and CYP2C9/SV2A Polymorphism in Early Post-Traumatic Seizures: A Multicentric Prospective Randomized Trial
NCT07072624 is registered in ClinicalTrials.gov with All India Institute of Medical Sciences, Jodhpur as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessing Phenytoin and Levetiracetam Efficacy, Cost-Effectiveness, and CYP2C9/SV2A Polymorphism in Early Post-Traumatic Seizures: A Multicentric Prospective Randomized Trial
- Lead sponsor
- All India Institute of Medical Sciences, Jodhpur
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- July 23, 2025
- Completion date
- March 15, 2028
- Enrollment
- 1,260 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
seizures, traumatic brain injuries, traumatic brain injury (tbi) patients